IHE vs XPH

iShares U.S. Pharmaceuticals ETF against State Street SPDR S&P Pharmaceuticals ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
40%
53 shared positions
Fee gap
2 bp
XPH is cheaper
1-year return gap
0.4 pts
XPH is ahead
Larger fund
IHE
$1.6B

Side by side

IHEXPH
FundiShares U.S. Pharmaceuticals ETFState Street SPDR S&P Pharmaceuticals ETF
IssueriSharesState Street SPDR
CategoryHealth CareHealth Care
Expense ratio0.37%0.35%
Assets$1.6B$462M
Average daily dollar volume$22M$15M
ListedMay 1, 2006Jun 19, 2006
FrenzyCap score5870
1-month return−1.2%−4.9%
3-month return+0.1%−3.3%
Year to date+18.0%+15.4%
1-year return+33.1%+33.5%
30-day volatility14.4%21.3%
Worst drawdown, 1 year−9.2%−15.1%
Trailing 12-month yield1.43%0.42%
Holdings5762
Top 10 weight79.2%22.7%
Look-through P/E49.6—
Holdings vs fair value+7.2%+18.3%
Holdings above 200-day average82%59%
Net flow, latest 3 reported months+$8.2M thru Jun 2026+$47M thru Jun 2026
30-day implied volatility20.5%28.4%
Holdings as ofas of Oct 8, 2026issuer dataas of Oct 8, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

100% of IHE · 91% of XPH
HoldingIHEXPH
VTRS4.55%2.15%
LLY24.14%2.11%
CORT2.56%2.08%
PFE4.65%2.04%
ZTS4.63%2.02%
MRK4.48%1.96%
JNJ22.28%1.95%
ELAN2.56%1.95%
RPRX4.30%1.89%
BMY4.29%1.88%
JAZZ3.28%1.87%
AXSM1.72%1.64%
LGND1.34%2.08%
DFTX1.04%1.83%
INDV0.95%2.07%
MANE0.90%2.58%
AMRX0.82%2.31%
OGN0.82%2.04%
EWTX0.73%1.84%
AMLX0.64%1.71%
TARS0.63%1.77%
ELVN0.59%1.44%
SUPN0.56%2.04%
PBH0.52%2.00%
LQDA0.47%0.82%

Sector mix of the stock holdings

SectorIHEXPHGap
Health Care99.8%99.2%+0.7%
Technology0.1%0.8%−0.7%

More: full overlap table · IHE holdings · XPH holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.